Search Within

Jacqueline Bromberg

Formats
  1. Journal Article (90)
  2. Meeting Abstract (49)
  3. Book Section (2)
Groups
  1. Breast Medicine Service (141)
  2. Department of Medicine (141)
  3. GSK Faculty (141)
  4. Solid Tumor Oncology Division (141)
  5. Sloan Kettering Institute Postdocs (50)
  6. Survivorship Research (37)

More Groups

People
  1. Larry Norton (20)
  2. Shanu Modi (20)
  3. Tiffany Traina (17)
  4. David Lyden (16)
  5. Clifford Hudis (15)
  6. Chau Dang (14)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (3)
  6. 2020 (10)

More Years

Publications
  1. Cancer Research (24)
  2. Journal of Clinical Oncology (12)
  3. Proceedings of the National Academy of Sciences of the United States of America (8)
  4. Journal of Vascular and Interventional Radiology (6)
  5. Annals of Oncology (5)
  6. Clinical Cancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. Nature Publishing Group (16)
  3. American Society of Clinical Oncology (13)
  4. Oxford University Press (11)
  5. Elsevier Inc. (10)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (141)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Inflammation and cancer: IL-6 and STAT3 complete the link
    Journal Article

    Bromberg, J.; Wang, T. C.
    Cancer Cell (2009)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate Stat3 activation via IL-6 production in human lung adenocarcinomas
    Meeting Abstract

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium (Tris DBA), an N-myristoyltransferase 1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Meeting Abstract

    Arbiser, I. L.; Bhandarkar, S.; Bromberg, J.; Selvakumar, P.; Sharma, R. K.; Fried, L.; Govindarajan, B.
    Journal of Investigative Dermatology (2008)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness
    Journal Article

    De La Iglesia, N.; Konopka, G.; Lim, K. L.; Nutt, C. L.; Bromberg, J. F.; Frank, D. A.; Mischel, P. S.; Louis, D. N.; Bonni, A.
    The Journal of Neuroscience (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Journal Article

    Bhandarkar, S. S.; Bromberg, J.; Carrillo, C.; Selvakumar, P.; Sharma, R. K.; Perry, B. N.; Govindarajan, B.; Fried, L.; Sohn, A.; Reddy, K.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
    Journal Article

    Gao, S. P.; Mark, K. G.; Leslie, K.; Pao, W.; Motoi, N.; Gerald, W. L.; Travis, W. D.; Bornmann, W.; Veach, D.; Clarkson, B.; more...
    Journal of Clinical Investigation (2007)

    Fulltext@MSK | Save
  • Increased dose density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C.; Panageas, K. S.; Atienza, M.; Norton, L.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
    Journal Article

    Berishaj, M.; Gao, S. P.; Ahmed, S.; Leslie, K.; Al-Ahmadie, H.; Gerald, W. L.; Bornmann, W.; Bromberg, J. F.
    Breast Cancer Research (2007)

    Fulltext@MSK | Save